Multinational Companies with Revenue Growth Plans for New Year

Published: 2005-01-06 06:59:00

Updated: 2005-01-06 06:59:00

It is expected that many of multinational pharmaceutical companies operating in Korea will drive higher revenues for the new year, where the majority of them came short of their last year's revenue objectives due to reasons of prolonged economic slump and of the various pressures affecting their ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK